Reduction of the Carbapenemase Inactivation Method (CIM) assay time by real-time PCR

Autor: P. Laksanalamai, R. Myers, T. Maruca, C. Dominguez, S. Fisseha, R. Tower, F. Haque, Pornpat Athamanolap, D. Torpey, J. Ortega

Publikováno v: Journal of microbiological methods. 178

Carbapenemase Inactivation Method (CIM) is a test to detect presence of the carbapenemase in Gram-negative bacteria. Determination of the carbapenemase production by inactivation of meropenem requires that a zone of control E. coli inhibition be meas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fa315c91b67ab9b9a46eff552923dd
https://pubmed.ncbi.nlm.nih.gov/33031896

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Naltrexone Is Associated With Reduced Drinking by Alcohol Dependent Patients Receiving Antidepressants for Mood and Anxiety Symptoms: Results From VA Cooperative Study No. 425, 'Naltrexone in the Treatment of Alcoholism'

Autor: Bryon Adinoff, S. Kilby, B. Kinne, C. Shaw, J. DeStefano, K. Gamel, S. Nixon, K. Conti, R. Lewandowski, R. Joswick, R. Lutz, S. Plumb, A. Butcher, J. Collins, J. Siegris, S. Kushner, S. Shives, D. Bertoch, N. Banks, H. Engebretson, J. Fields, I. Rhew, J. Weintraub, J. Grabowski, K. Drexler, J. Hermos, H. Adkins, F. Pohlman, S. Chermack, Joseph M. Collins, L. Rugle, P. Stevenson, L. Madlock, C. Arnold-Hunter, J. Kelly, Joyce A. Cramer, L. Moffet, M. Andem, K. Lunna, H. MacAskill, E. Richardson, J. Williams, Y. Ruiz, L. Haynes-Tucker, S. Harris, S. Brown, W. Krol, L. Linzy, S. Fleming, N. Lynch, H. Zegarna, L. Siklosky, M. Cowie, P. Banys, H. Behr, K. Walker, C. Hackett, J. Wickis, D. Briones, A. Quintero, C. Dalzell, J. Hunter, D. Torpey, Mark W. Miller, John H. Krystal, C. Williams, B. Cotton-Brown, J. Fiery, Sabrina Poole, R. Head, W. Hill, Robert A. Rosenheck, S. Staccone, T. Burke, S. Johnson, B. Sullivan, M. Dean, V. Ruscigno, S. Clinton, G. Harris, O. Kausch, P. Casadonte, R. Royal, A. Holmes, K. Shaffer, M. Willey-Allen, J. Arflin, R. Murray, B. Hudson, A. Scheamania, D. Savage, P. Charnley, F. Mohammad, S. Dyanick, A. Connelly, T. Owens, I. Maany, Ralitza Gueorguieva, J. Corder, C. Stock, G. Kaplan, L. Burney, J. McNeely, C. Cartier, R. Wancha, M. Rhoads, J. Pena, M. FeBornstein, C. Messick, A. Saxon, E. Moeller

Publikováno v: Alcoholism: Clinical and Experimental Research. 32:85-91

Background: It is not clear whether naltrexone is effective in reducing alcohol consumption among patients with clinically significant mood symptoms and whether naltrexone favorably interacts with antidepressant medications when they are co-prescribe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1bdfed25d1e596051811887b4435aebf
https://doi.org/10.1111/j.1530-0277.2007.00555.x

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.